It is a dubious disease in the area of infectious respiratory digestive and endocrine disorders. Clinical manifestations are complex and often involve multi-system complications. Early identification and standardized clinical treatment are essential for improving prognosis.
Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological activation. The platform can assist in matching a team of nationally and internationally authoritative experts to provide accurate diagnosis and treatment programs. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat infectious respiratory digestive endocrine disorders have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of cardiac arrhythmiasoma and connective sclerosis. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.